Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP630406.RApnCmUpgPJ9CDzQqVbl8PzDlVu1y0mq8U5czde5cIlig130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP630406.RApnCmUpgPJ9CDzQqVbl8PzDlVu1y0mq8U5czde5cIlig130_assertion type Assertion NP630406.RApnCmUpgPJ9CDzQqVbl8PzDlVu1y0mq8U5czde5cIlig130_head.
- NP630406.RApnCmUpgPJ9CDzQqVbl8PzDlVu1y0mq8U5czde5cIlig130_assertion description "[Administration of cisplatin without anthracyclines correlates with a high rate of pCR after primary chemotherapy in patients with p63-positive BC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP630406.RApnCmUpgPJ9CDzQqVbl8PzDlVu1y0mq8U5czde5cIlig130_provenance.
- NP630406.RApnCmUpgPJ9CDzQqVbl8PzDlVu1y0mq8U5czde5cIlig130_assertion evidence source_evidence_literature NP630406.RApnCmUpgPJ9CDzQqVbl8PzDlVu1y0mq8U5czde5cIlig130_provenance.
- NP630406.RApnCmUpgPJ9CDzQqVbl8PzDlVu1y0mq8U5czde5cIlig130_assertion SIO_000772 17639392 NP630406.RApnCmUpgPJ9CDzQqVbl8PzDlVu1y0mq8U5czde5cIlig130_provenance.
- NP630406.RApnCmUpgPJ9CDzQqVbl8PzDlVu1y0mq8U5czde5cIlig130_assertion wasDerivedFrom befree-20140225 NP630406.RApnCmUpgPJ9CDzQqVbl8PzDlVu1y0mq8U5czde5cIlig130_provenance.
- NP630406.RApnCmUpgPJ9CDzQqVbl8PzDlVu1y0mq8U5czde5cIlig130_assertion wasGeneratedBy ECO_0000203 NP630406.RApnCmUpgPJ9CDzQqVbl8PzDlVu1y0mq8U5czde5cIlig130_provenance.